Based on 4 analysts giving stock ratings to Rapid Micro Biosystems Inc in the past month.
In the current month, RPID has received 3 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. RPID average Analyst price target in the last month is 6.667.
Based on analysts' estimates, RPID EPS is projected to reach -0.200 in FY2026Q3, following reported EPS of -0.267 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
The market expectation was USD -0.27, while Rapid Micro Biosystems IncRPID's earnings per share (EPS) for the previous quarter was USD -0.31. EPS for the next quarter is expected at USD -0.20.